Walvax Biotechnology Co., Ltd. (SHE:300142)
China · Delayed Price · Currency is CNY 10.89
-0.62 (-5.39%)
Oct 30, 2026, 3:04 PM CST
Walvax Biotechnology Market Cap
Walvax Biotechnology has a market cap or net worth of 17.42 billion as of October 30, 2026. It is the 5,494th most valuable company in the world and the 867th biggest in China. Its market cap has decreased by 7.56% in one year.
Market Cap
17.42B
Enterprise Value
18.27B
Revenue
1.85B
Global Rank
Country Rank
#867 China
PE Ratio
799.56
ChartMarket Cap Chart
Since November 12, 2010, Walvax Biotechnology's market cap has increased from 13.63B to 17.42B, an increase of 27.74%. That is a compound annual growth rate of 1.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 17.42B | -0.18% |
| Dec 31, 2025 | 17.45B | -9.69% |
| Dec 31, 2024 | 19.32B | -48.62% |
| Dec 29, 2023 | 37.60B | -41.50% |
| Dec 30, 2022 | 64.27B | -28.12% |
| Dec 31, 2021 | 89.42B | 50.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.47B |
| Tasly Pharmaceutical Group | 20.33B |
| Guangdong Zhongsheng Pharmaceutical | 20.08B |
| Hybio Pharmaceutical | 19.71B |
| Jilin Aodong Pharmaceutical Group | 19.22B |
| Joincare Pharmaceutical Group Industry | 18.20B |
| Shanghai Haoyuan Chemexpress | 17.72B |
| Kangmei Pharmaceutical | 17.42B |